These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30819015)

  • 1. Zeolite-fibrin clot composite as a haemostatic agent for haemophilia A.
    Shang X; Li YL; Chen H; Yu L; Wang Z; Xiao L; Fan J
    J Biomater Appl; 2019 May; 33(10):1427-1433. PubMed ID: 30819015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General haemostatic agents--fact or fiction?
    Hedner U
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():33-6. PubMed ID: 12214145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin glue and clinical impact on haemophilia care.
    Kavakli K
    Haemophilia; 1999 Nov; 5(6):392-6. PubMed ID: 10583525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a novel mineral based haemostatic agent consisting of a combination of bentonite and zeolite minerals.
    Mortazavi SM; Atefi A; Roshan-Shomal P; Raadpey N; Mortazavi G
    J Ayub Med Coll Abbottabad; 2009; 21(1):3-7. PubMed ID: 20364729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safer circumcision in patients with haemophilia: the use of fibrin glue for local haemostasis.
    Avanogmacr;lu A; Celik A; Ulman I; Ozcan C; Kavakli K; Nişli G; Gökdemir A
    BJU Int; 1999 Jan; 83(1):91-4. PubMed ID: 10233459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the overall haemostatic effect of recombinant factor VIIa by measuring thrombin generation and stability of fibrin clots.
    Dargaud Y; Prevost C; Lienhart A; Claude Bordet J; Negrier C
    Haemophilia; 2011 Nov; 17(6):957-61. PubMed ID: 21453422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic rationale for factor XIII cotreatment in haemophilia.
    Beckman JD; Wolberg AS
    Haemophilia; 2019 Nov; 25(6):e377-e378. PubMed ID: 31577382
    [No Abstract]   [Full Text] [Related]  

  • 8. Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography.
    Sørensen B; Ingerslev J
    Haemophilia; 2005 Nov; 11 Suppl 1():1-6. PubMed ID: 16219042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of fibrin clot structure after factor VIII injection in haemophilia A patients treated on demand.
    Antovic A; Mikovic D; Elezovic I; Zabczyk M; Hutenby K; Antovic JP
    Thromb Haemost; 2014 Apr; 111(4):656-61. PubMed ID: 24258360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma-derived biological medicines used to promote haemostasis.
    Ofosu FA; Freedman J; Semple JW
    Thromb Haemost; 2008 May; 99(5):851-62. PubMed ID: 18449414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local fibrin glue and chitosan-based dressings in haemophilia surgery.
    Rodriguez-Merchan EC
    Blood Coagul Fibrinolysis; 2012 Sep; 23(6):473-6. PubMed ID: 22688558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia.
    Martinowitz U; Luboshitz J; Bashari D; Ravid B; Gorina E; Regan L; Stass H; Lubetsky A
    Haemophilia; 2009 May; 15(3):676-85. PubMed ID: 19298381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of acquired haemophilia A in severe Covid-19: Haemostatic bridging with emicizumab to keep the balance between bleeding and thrombosis.
    Gelbenegger G; Traby L; Rahimi N; Knöbl P
    Br J Clin Pharmacol; 2023 Feb; 89(2):908-913. PubMed ID: 36369653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The haemostatic plug in haemophilia A: a morphological study of haemostatic plug formation in bleeding time skin wounds of patients with severe haemophilia A.
    Sixma JJ; van den Berg A
    Br J Haematol; 1984 Dec; 58(4):741-53. PubMed ID: 6518139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative and humane tail bleeding assay for efficacy evaluation of antihaemophilic factors in haemophilia A mice.
    Molina ES; Fujita A; Sogayar MC; Demasi MA
    Haemophilia; 2014 Nov; 20(6):e392-8. PubMed ID: 24975823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding complications after oral surgery in outpatients with compromised haemostasis: incidence and management.
    Reich W; Kriwalsky MS; Wolf HH; Schubert J
    Oral Maxillofac Surg; 2009 Jun; 13(2):73-7. PubMed ID: 19319581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The important impact of dental care on haemostatic treatment burden in patients with mild haemophilia.
    Raso S; Napolitano M; Sirocchi D; Siragusa S; Hermans C
    Haemophilia; 2022 Nov; 28(6):996-999. PubMed ID: 35879819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose factor VIIa improves clot structure and stability in a model of haemophilia B.
    Wolberg AS; Allen GA; Monroe DM; Hedner U; Roberts HR; Hoffman M
    Br J Haematol; 2005 Dec; 131(5):645-55. PubMed ID: 16351642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of local pro-coagulant haemostatic agents for intra-cavity control of haemorrhage after trauma.
    Navarro A; Brooks A
    Eur J Trauma Emerg Surg; 2015 Oct; 41(5):493-500. PubMed ID: 26037982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity in haemophilia patients: effect on bleeding frequency, clotting factor concentrate usage, and haemostatic and fibrinolytic parameters.
    Tuinenburg A; Biere-Rafi S; Peters M; Verhamme P; Peerlinck K; Kruip MJ; Laros-Van Gorkom BA; Roest M; Meijers JC; Kamphuisen PW; Schutgens RE
    Haemophilia; 2013 Sep; 19(5):744-52. PubMed ID: 23659471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.